With the development of genome-wide association study (GWAS), an increasing number of genetic variables have been confirmed to be associated with breast cancer. Furthermore, an increasing number of studies from Asian populations are becoming available. Few GWAS loci have been replicated in the Chinese Han population. In a case–control study of breast cancer in the Henan Tumor Hospital (253 cases/339 controls), we evaluated five SNPs from GWAS of populations of European or Asian ancestry. In order to evaluate the contribution of genetic factors to population differences in breast cancer subtypes, all cases are defined by estrogen (ER), progesterone (PR) receptor, Human epidermal growth factor receptor - 2 (HER2), and Ki67 status. Different genotypes of rs3803662 (TOX3)/ (TNRC9)) in the case group and the control group are statistically significant (P = 0.044), but the ones of rs10069690 (TERT), rs2046210 (6q25.1), rs2981582 (EGFR2), and rs889312 (MAP3K1) have no significant statistical differences with breast cancer (P = 0.772, 0.308, 0.376, 0.468). The allelic frequencies of rs3803662 between the case group and the control group differ in recessive genetic models (odds ratio (OR) = 2.04, 95 % confidence interval (CI) 1.14–3.66) and in con-dominant inheritance models (OR = 2.17, 95 % CI 1.18–4.00). Compared with AA and GA, GG increased the risk of breast cancer (P = 0.017, 0.013). The genotype of rs2046210 (6q25.1), rs2981582 (EGFR2), rs889312 (MAP3K1), and rs3803662 (TOX3/TNRC9) has no statistical differences in different subtypes of breast cancer. Five common breast cancer susceptibility loci from GWAS are not strongly associated with breast cancer risk among the Han Chinese of the Henan province; only rs3803662 (TOX3/TNRC9) is confirmed to increase the risk of breast cancer. The different genotypes of five loci distribute equally in different subtypes of breast cancer.
Breast cancer Subtypes of breast cancer SNPs GWAS
This is a preview of subscription content, log in to check access.
We thank all subjects for providing the DNA and information necessary for our study. We also thank Central Laboratory of Henan Tumor Hospital and Shanghai Genesky Bio-Tech Co., Ltd. (http://biotech.geneskies.com/index.html), for valuable help with the isolation of DNA and the test of SNPs.
Compliance with ethical standards
Conflicts of interest
Esther MJ, Hopper JL, Beck JC, et al. The breast cancer family registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res. 2004;6:R375–89.CrossRefGoogle Scholar
Long J, Delahanty RJ, Li G. A common deletion in the APOBEC3 genes and breast cancer risk. J Natl Cancer Inst. 2013;14.Google Scholar
Gold B, Kirchhoff T, Stefanov S, et al. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A. 2008;105:4340–5.CrossRefPubMedPubMedCentralGoogle Scholar
Stacey SN, Manolescu A, Sulem P, et al. Common variants on chromosome 5p12 confer usceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2008;40:703–6.CrossRefPubMedGoogle Scholar
Stacey SN, Manolescu A, Sulem P, et al. Common variants on chromosomes 2q35 nd 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2007;39:865–9.CrossRefPubMedGoogle Scholar
Garcia-Closas M, Hall P, Nevanlinna H, et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet. 2008;4, e1000054.CrossRefPubMedPubMedCentralGoogle Scholar
Han W, Woo JH, Yu J-H, et al. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype. Cancer Epidemiol Biomarkers Prev. 2011;20:793–8.CrossRefPubMedGoogle Scholar
Mulligan AM, Couch FJ, Barrowdale D, et al. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1/2. Breast Cancer Res. 2011;13:R110.CrossRefPubMedPubMedCentralGoogle Scholar
Dai J, Hu Z, Yue Y, et al. Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women. Breast Cancer Res. 2012;14:R17.CrossRefPubMedPubMedCentralGoogle Scholar
Hein R, Maranian M, et al. Comparison of 6q25 breast cancer hits from Asian an European Genome Wide Association studies in the Breast Cancer Association Consortium (BCAC). Plos One. 2012;7(8), e42380.CrossRefPubMedPubMedCentralGoogle Scholar
Palmer JR, Ruiz-Narvaez EA, Rotimi CN, et al. Genetic susceptibility loci for subtypes of breast cancer in an African American population. Cancer Epidemiol Biomarkers Prev. 2013;22:127–34.CrossRefPubMedGoogle Scholar
Zheng W, Wen W, Gao YT, et al. Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J Natl Cancer Inst. 2010;102:972–81.CrossRefPubMedPubMedCentralGoogle Scholar
Gudmundsdottir ET, Barkardottir RB, Adalgeir A, et al. The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients. BMC Cancer. 2012;12:621.CrossRefPubMedPubMedCentralGoogle Scholar
Xi W, Qing-Qing X, Liang G, et al. Quantitative Assessment of the Association between rs2046210 at 6q25. 1 and breast cancer risk. PLoS ONE. 2013;8(6), e65206.CrossRefGoogle Scholar